$2,316 in research paymentsStomach NeoplasmsStomach DiseasesPaclitaxelRamucirumab
Peter C. Enzinger, DR
NPI1710954391PAC ID8729270335
- Medicare services, 2024
- 417
- Medicare patients, 2024
- 135
- Part D claims, 2024
- 243
- Clinical trials
- 2
- MIPS score, 2024
- 84
- Practice address
- 450 Brookline Avenue, Boston, MA 02115
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Peter Enzinger's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Peter C. Enzinger is a medical oncologist in Boston, Massachusetts
Peter Enzinger practices at Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute.
Peter Enzinger's NPI, 1710954391, was assigned on March 2, 2006. Peter Enzinger graduated from Warren Alpert Medical School of Brown University in 1992. Peter Enzinger holds Massachusetts license 160952.
NPI and contact details
- NPI
- 1710954391NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8729270335
- NPI enumeration date
- March 2, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 60
- Medical school graduation
- 1992
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Peter C. Enzinger practices at Dana-Farber Cancer Institute in Boston, Massachusetts
Peter Enzinger's primary practice is Dana-Farber Cancer Institute, at 450 Brookline Avenue, Boston, MA 02115.
- Dana-Farber Cancer Institute450 Brookline Avenue, Boston, MA 02115
Source: Dmand AI Affiliation Data
Peter C. Enzinger is affiliated with 7 sites of care and 1 medical group
Peter Enzinger's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Peter Enzinger is also affiliated with Massachusetts General Hospital. The medical group on file is Binney Medical Group. Dmand AI also links Peter Enzinger to 3 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.
Massachusetts General HospitalBinney Medical Group3 hospitalsNames with a free account1 group practice or clinicName with a free account1 home health agencyName with a free account
See all 8 affiliations for Peter EnzingerSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Peter C. Enzinger's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Peter Enzinger practices, 7 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dana-Farber Cancer Institute | Available with a free account |
| +6 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Peter Enzinger practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Dana-Farber Cancer Institute and 6.2K+ hospitals, with verified contacts in the same login.
Peter C. Enzinger is one of 290 medical oncologists in Massachusetts
Medical oncology is Peter Enzinger's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Peter Enzinger is licensed in Massachusetts.
Specialties and state licenses
- Medical oncology, MassachusettsPrimary
Medical oncologists near Peter Enzinger
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
290medical oncologists in Massachusetts228medical oncologists in Boston96medical oncologists at Dana-Farber Cancer Institute
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Peter C. Enzinger billed Medicare for 417 services in 2024
CMS data shows 417 Medicare services from Peter Enzinger across 4 procedure codes in 2024, for 135 Medicare patients. Medicare paid $42,847 for them.
Medicare services, 2024417
Medicare patients135
Paid by Medicare$42,847
Procedure codes4
Peter Enzinger's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3032024: 41738%
Where Peter Enzinger's Medicare services took place, 2024
- In an office16038%
- In a facility25762%
Peter Enzinger compared with the Massachusetts median for medical oncologists, 2024
- Peter Enzinger
- Massachusetts median
- Medicare services
- 417vs 26060% above
- Medicare patients
- 135vs 10924% above
- Part D claims
- 98vs 6356% above
Medians across 259 medical oncologists in Massachusetts with Dmand AI profiles that report each measure.
Peter Enzinger's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Peter Enzinger?
Medicare shows one payer. Book a meeting to get commercial claims data for Peter Enzinger and other medical oncologists in Massachusetts.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Peter C. Enzinger treated 135 Medicare patients in 2024, average age 73
CMS counts 135 Medicare patients who saw Peter Enzinger in 2024. The largest group is 65 to 74, with 72 patients. 72% of them have high cholesterol, and 70% have high blood pressure. 18% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Peter Enzinger's median patient age at 68, with 48% women.
Medicare patients, 2024135
Average age73
Average risk score2.05
Also on Medicaid18%
Peter Enzinger's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Peter Enzinger's Medicare patients by sex, 2024
- Women6548%
- Men7052%
Chronic conditions among Peter Enzinger's Medicare patients, 2024
- High cholesterol72%
- High blood pressure70%
- Arthritis47%
- Cancer39%
- Ischemic heart disease35%
- Anxiety33%
- Diabetes27%
- Mood disorders27%
Share of Medicare patients with each condition. A patient can have several.
Peter Enzinger's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women48%
- Men51%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Peter C. Enzinger wrote 243 Medicare Part D claims in 2024
In 2024, Peter Enzinger wrote 243 Medicare Part D claims for 50 patients. 79% of them were for generic drugs. CMS names the drug for 98 of them, across 6 drugs with 11 or more claims each, at $956 in total drug cost. In 2023, CMS named 188 claims across 9 drugs.
Part D claims, 2024243
Drugs named by CMS6
Total drug cost$956
Part D patients50
Peter Enzinger's Part D claims by kind of drug, 2024
- Generic191 claims79%
- Brand-name and other52 claims21%
Peter Enzinger's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Peter Enzinger's Part D claims, 2024
- Opioids8%20 of 243 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1882024: 9848%
Drugs named by CMS: 6 in 2024, 9 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Peter C. Enzinger scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Peter Enzinger for performance year 2024, reported as part of a group. Peter Enzinger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Peter Enzinger as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Peter Enzinger's MIPS scores, performance year 2024
- 84of 100Final score
- 65of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 69of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find medical oncologists like Peter Enzinger by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Peter C. Enzinger has worked on 2 clinical trials
Dmand AI links Peter Enzinger to 2 clinical trials. Conditions studied include Stomach Neoplasms and Stomach Diseases. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Peter Enzinger that name 2 trials.
Conditions in Peter Enzinger's trials
- Stomach Neoplasms
- Stomach Diseases
Investigators on the most trials with Peter Enzinger
Recent clinical trials with Peter Enzinger
$2,217 in research paymentsCapecitabineCisplatinRamucirumab
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Peter C. Enzinger received $203,356 in industry payments from 2016 to 2025
CMS Open Payments shows 133 general payments to Peter Enzinger from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 80% of the total. Merck Sharp & Dohme Corporation paid the most, $94,033. It also lists 3 research payments totaling $4,926 from 2018 to 2025, naming 2 clinical trials.
General payments to Peter Enzinger by program year, 2016 to 2025
General payments to Peter Enzinger by kind, 2016 to 2025
$203.4Kin total
- Consulting fees$162,24380%
- Speaker and faculty fees$21,39811%
- Travel and lodging$9,7445%
- Honoraria$7,0803%
- Food and beverage$2,8911%
Companies that paid Peter Enzinger the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Peter C. Enzinger graduated from Warren Alpert Medical School of Brown University
Peter Enzinger graduated from Warren Alpert Medical School of Brown University in 1992.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Peter C. Enzinger's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Peter C. Enzinger
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Peter C. Enzinger's NPI number?
Peter C. Enzinger's NPI number is 1710954391. It was assigned on March 2, 2006, and it is active in the NPI Registry.
What does Peter C. Enzinger specialize in?
Peter C. Enzinger is a medical oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Peter C. Enzinger practice?
Peter Enzinger practices at 450 Brookline Avenue, Boston, MA 02115. Peter Enzinger's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dmand AI also links Peter Enzinger to 3 hospitals, 1 group practice or clinic and 1 home health agency.
What is Peter C. Enzinger's medical license number?
Peter Enzinger holds Massachusetts license 160952.
Which hospitals is Peter C. Enzinger affiliated with?
Peter Enzinger practices at Dana-Farber Cancer Institute in Boston, Massachusetts. Peter Enzinger is also affiliated with Massachusetts General Hospital. Dmand AI links Peter Enzinger to 3 more hospitals.
What medical group is Peter C. Enzinger part of?
Peter Enzinger is linked to Binney Medical Group.
Does Peter C. Enzinger accept Medicare?
Yes. CMS data shows Peter Enzinger billed Medicare for 417 services in 2024, and Peter Enzinger accepts Medicare assignment.
Does Peter C. Enzinger offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Peter Enzinger as offering telehealth services.
What is Peter C. Enzinger's MIPS score?
Peter Enzinger's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
How many Medicare patients does Peter C. Enzinger see?
CMS counts 135 Medicare patients who saw Peter Enzinger in 2024, with an average age of 73.
Show 6 more questionsShow fewer questions
What services does Peter C. Enzinger bill to Medicare?
In 2024, Peter Enzinger's most billed Medicare services were office visit, established patient (99215), office visit, established patient (99214) and hospital inpatient care (99232).
Where did Peter C. Enzinger go to medical school?
Peter Enzinger graduated from Warren Alpert Medical School of Brown University in 1992.
What drugs does Peter C. Enzinger prescribe most?
In 2024 Medicare Part D data, Peter Enzinger's most prescribed drugs by claims were Dexamethasone, Prochlorperazine Maleate and Ondansetron HCl.
Has Peter C. Enzinger received payments from drug or device companies?
CMS Open Payments shows $203,356 in general payments to Peter Enzinger from 26 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.
How long has Peter C. Enzinger been practicing?
Peter Enzinger graduated from medical school in 1992, 34 years ago.
Does Peter C. Enzinger do research?
Peter Enzinger has worked on 2 clinical trials.
Selling to medical oncology practices?
See medical oncologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card